We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBN:NYSEICICI Bank Limited Analysis

Data as of 2026-04-09 - not real-time

$27.21

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its longer‑term moving averages, signaling a bearish technical backdrop, while the 20‑day SMA sits under the 50‑day SMA and both are under the 200‑day SMA. RSI hovers around the midpoint, suggesting neither overbought nor oversold conditions, and the MACD histogram has turned positive, hinting at a modest bullish momentum despite an overall bearish trend. Volume has been on a downtrend, and the price is hovering near a clear support zone with resistance ahead, creating a narrow trading range. The beta is low, indicating limited sensitivity to broader market swings, but the 30‑day volatility remains elevated, reflecting pronounced price swings.
Fundamentally, the bank posts solid profitability margins and a low payout ratio, supporting dividend sustainability. The price‑to‑earnings multiple is only marginally above the industry average, while the price‑to‑book ratio is elevated, suggesting a mixed valuation picture. Analyst consensus leans strongly toward buying, and target prices imply a sizable upside from current levels. The fear‑and‑greed gauge sits in the extreme greed zone, underscoring bullish market sentiment toward the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish moving‑average crossover
  • Decreasing trading volume
  • Proximity to established support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to target price
  • Strong earnings margins and low dividend payout
  • Positive MACD histogram indicating momentum shift

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term growth potential in Indian banking sector
  • Diversified product suite and expanding retail base
  • Robust capital position and sustainable dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth3.00%
Profit Margin27.51%
P/E Ratio17.3
ROE16.80%
ROA2.14%
P/B Ratio2.6
Industry P/E17.2

Technical Analysis

TrendBearish
RSI51.2
Support$25.08
Resistance$27.92
MA 20$26.34
MA 50$28.62
MA 200$30.83
MACDBullish
VolumeDecreasing
Fear & Greed Index83.54

Valuation

Target Price$36.40
Upside/Downside33.77%
GradeUndervalued
TypeBlend
Dividend Yield0.96%

Risk Assessment

Beta0.47
Volatility31.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.